HALIFAX, NS / ACCESS Newswire / / Namibia Critical Metals Inc. ("Namibia Critical Metals" or the "Company" or "NMI") ...

Robust and clinically meaningful benefits across all three key markers of disease – 68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 depositsConsistent ...

This study presents a large, systematically curated catalog of non-canonical open reading frames (ncORFs) in human and mouse by reanalyzing nearly 400 Ribo-seq datasets using a standardized pipeline; ...

American families are facing a convergence of economic pressures that are redefining what it means to live comfortably. After ...

SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the ...

A new scoring system using common clinical parameters accurately identifies chronic liver disease patients with a ...

How rich is Tems in 2025? Inside her net worth, revenue streams, and the career milestones that built her global empire.

The conforming loan limit is the maximum amount of money a homebuyer can borrow using a conventional mortgage that's eligible for purchase by Fannie Mae and Freddie Mac. The Federal Housing ...

HONOLULU — A novel “moderate-affinity iron chaperone” known as ATH434 (Alterity Therapeutics) may slow disease progression in patients with multiple system atrophy (MSA), new research suggested. The ...

CRANBERRY TOWNSHIP, Pa. (AP) — CRANBERRY TOWNSHIP, Pa. (AP) — MSA Safety Inc. (MSA) on Tuesday reported third-quarter earnings of $69.6 million. The Cranberry Township, Pennsylvania-based company said ...

Fintel reports that on July 16, 2025, Stifel initiated coverage of MSA Safety (NYSE:MSA) with a Hold recommendation. Analyst Price Forecast Suggests 5.34% Upside As of June 20, 2025, the average ...

The cause of MSA remains unknown. Several lines of evidence suggest that inflammation could contribute to neurodegeneration in MSA. [9–11] Microglia are the primary immune effector cells in the brain.